Menu Search
Equities

Addus Homecare Corp

ADUS:NSQ

Addus Homecare Corp

Actions
Health CareHealth Care Providers
  • Price (USD)127.58
  • Today's Change-1.50 / -1.16%
  • Shares traded140.60k
  • 1 Year change+53.66%
  • Beta1.0294
Data delayed at least 15 minutes, as of Nov 08 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 16-Nov-23
  • 15-Aug-24
  • 19-Sep-24
  • 17-Oct-24
  • 07-Nov-24
Select bar for recommendation details.
Recommendations07-Nov-24
Buy5
Outperform5
Hold0
Sell1
Strong Sell0

Share price forecast in USD

The 10 analysts offering 12 month price targets for Addus Homecare Corporation have a median target of 143.00, with a high estimate of 160.00 and a low estimate of 83.00. The median estimate represents a 12.09% increase from the last price of 127.58.
High25.4%160.00
Med12.1%143.00
Low-34.9%83.00

Earnings history & estimates in USD

On Nov 04, 2024, Addus Homecare Corporation reported 3rd quarter 2024 earnings of 1.30 per share. This result was in line with the consensus of the 10 analysts following the company and exceeded last year's 3rd quarter results by 13.04%.
The next earnings announcement is expected on Feb 24, 2025.
Average growth rate+3.58%
Addus Homecare Corporation reported annual 2023 earnings of 4.58 per share on Feb 26, 2024.
Average growth rate+16.65%
More ▼

Revenue history & estimates in USD

Addus HomeCare Corporation had 3rd quarter 2024 revenues of 289.79m. This bettered the 289.39m consensus of the 10 analysts covering the company. This was 15.18% above the prior year's 3rd quarter results.
Average growth rate+1.72%
Addus HomeCare Corporation had revenues for the full year 2023 of 1.06bn. This was 11.31% above the prior year's results.
Average growth rate+13.06%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.